In this Issue
Sodium-glucose transporter 2 inhibition and cardiovascular events in patients with diabetes: information from clinical trials and observational real-world data
Clinical Science (28 September 2018) 132 (18): 2003–2012.
The intestinal microbiota in the pathogenesis of inflammatory bowel diseases: new insights into complex disease
Clinical Science (28 September 2018) 132 (18): 2013–2028.
Proteomic analysis of exosomes reveals an association between cell invasiveness and exosomal bioactivity on endothelial and mesenchymal cell migration in vitro
Shayna Sharma; Mona Alharbi; Miharu Kobayashi; Andrew Lai; Dominic Guanzon; Felipe Zuñiga; Valeska Ormazabal; Carlos Palma; Katherin Scholz-Romero; Gregory E. Rice; John D. Hooper; Carlos Salomon
Clinical Science (28 September 2018) 132 (18): 2029–2044.
The renal protect function of erythropoietin after release of bilateral ureteral obstruction in a rat model
Chuan Chuan Ren; Wen Zhu; Qing Wei Wang; Yu Tao Lu; Yan Wang; Guo Xian Zhang; Jia Feng Xie; Jun Wei Wu; Zhi Ming Jia; Tao Zhang; Zhi Qiang Su; Jian Guo Wen
Clinical Science (28 September 2018) 132 (18): 2071–2085.
Cover ImageA scanning electron micrograph (digitally altered and colourized, 4000× magnification) depicting a mesenchymal stem cell (orange) encapsulated in a self-assembling peptide hydrogel. In volume 132, issue 17 of Clinical Science, McFetridge et al. discuss the use of hydrogel materials to unlock the potential of stem cell therapy to treat chronic kidney disease. This image was provided by the authors and produced in collaboration with Dr Simon Crawford at the Ramaciotti Centre for Cryo-Electron Microscopy, and the Monash Teaching Resource Support Unit.